Your browser doesn't support javascript.
loading
Effectiveness and safety of switching from originator to biosimilar adalimumab in patients with psoriasis.
Nielsen, Valdemar Wendelboe; Lund, Tamara Theresia; Gniadecki, Robert; Olsen, Rasmus Huan; Nissen, Christoffer Valdemar; Schwensen, Jakob Ferløv Baselius; Thomsen, Simon Francis.
  • Nielsen VW; Department of Dermato-Venereology & Wound Healing Centre, Bispebjerg Hospital, Copenhagen, Denmark.
  • Lund TT; Department of Dermato-Venereology & Wound Healing Centre, Bispebjerg Hospital, Copenhagen, Denmark.
  • Gniadecki R; Division of Dermatology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
  • Olsen RH; Department of Dermato-Venereology & Wound Healing Centre, Bispebjerg Hospital, Copenhagen, Denmark.
  • Nissen CV; Department of Clinical Pharmacology, Bispebjerg Hospital, Copenhagen, Denmark.
  • Schwensen JFB; Department of Dermato-Venereology & Wound Healing Centre, Bispebjerg Hospital, Copenhagen, Denmark.
  • Thomsen SF; Department of Dermato-Venereology & Wound Healing Centre, Bispebjerg Hospital, Copenhagen, Denmark.
Dermatol Ther ; 33(6): e14258, 2020 11.
Article en En | MEDLINE | ID: mdl-32865289

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Psoriasis Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Psoriasis Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article